Catalysts Driven Investment Opportunities

June 2011 | 4 pages | ID: C2356E63C36EN
MP Advisors

Abstracts

We are presenting a “Snapshot” of select upcoming catalysts (scientific and financial analysis) in the Biotech sector. The table lists the drug related catalysts for the Rising Star or Mature Biotech companies, our expectations, and possible stock price movements related to the event. This is the beginning of the series, which we will keep releasing in a timely manner. The catalysts include outcome of Advisory Committee Meetings (only June), PDUFA dates, and clinical trial data of the respective companies through October 2011.

Contents

COMPANIES MENTIONED

ArQule, Dendreon, Incyte, Micromet, Regeneron, Seattle Genetics, Biogen Idec, Celgene, Gilead, Onyx Pharma, Shire